AFICAMTEN

FDA Drug Profile — MYQORZO

Drug Details

Generic Name
AFICAMTEN
Brand Names
MYQORZO
Application Number
NDA219083
Sponsor
Cytokinetics Inc.
NDC Codes
4
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
AFICAMTEN

Indications and Usage

1 INDICATIONS AND USAGE MYQORZO is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. ( 1 )